MEDP NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Medpace Holdings Inc · Healthcare · Diagnostics & Research

Open interactive chart View report data Download investor PDF
Latest close 601.4 USD
11.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 21.5% above the Trend Line and sits at 74.9% of its 52-week range. The latest completed week returned 11.8%, after a 14.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is mixed with 41/100 conviction, while the latest news-sentiment score is 61/100. Near-term considerations: earnings are due in 82d.

Setup score 63 out of 100
Latest Close 601.4 USD 24 Jul 2026
1W Return 11.8% latest completed week
4W Return 14.1% short-term follow-through
12W Return 44.0% quarterly tape
Trend Breadth 53.8% 28 of 52 weeks active
Volume Ratio 1.7x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 3 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 11.8% Latest completed week; four-week move 14.1%. Indicator stack 30/88 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 41/100 conviction; expected move 8.2%. News sentiment 61/100 59 relevant articles in the latest sentiment read. Event risk 82d Next report is scheduled for 19 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 21.5% above the Trend Line and sits at 74.9% of its 52-week range. The latest completed week returned 11.8%, after a 14.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4312-week average 0.19

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.43Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 14.1% over four weeks, 44.0% over 12 weeks, and 34.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W11.8%
4W14.1%
12W44.0%
26W2.3%
52W34.4%
Active trend streak0 weeks
Active weeks in one year28
Trend breadth53.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.09Latest activity-pressure read.
Pressure change227.9%Four-week change in activity pressure.
Leadership8.07Latest relative-leadership reading.
RS change218.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 94% Model confidence 94%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength41/100Blend of value, momentum, and quality. Underlying universe rank 60; rank 1 is best.
Value7/100Relative valuation strength. Underlying universe rank 94; rank 1 is best.
Quality91/100Profitability and accounting quality. Underlying universe rank 10; rank 1 is best.
Momentum75/100Medium-term price momentum. Underlying universe rank 26; rank 1 is best.
Growth94/100Revenue and earnings growth. Underlying universe rank 7; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
34.2x
Price divided by trailing earnings.
Price / sales
6.0x
Market value relative to trailing revenue.
EV / EBITDA
27.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
28.8%
Gross profit retained from each unit of revenue.
Operating margin
21.1%
Operating profit retained from revenue.
Free-cash-flow margin
28.3%
Free cash flow generated from revenue.
Return on invested capital
941.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
24.7%
Latest one-year revenue growth.
EPS growth
17.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
21.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
1.5%
Net share repurchases relative to market value.
Shareholder yield
1.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

MEDP shows mixed options pressure with a 41/100 conviction score, put-call volume ratio of 1.02, expected move of 8.2%, and Sharemaestro trend signal inactive.

Conviction41/100
Expected move8.2%
Put/call volume1.02
Pressure-13
Speculation41
Volatility59
Trend agreement81
Open options detail
Insider activity15 / 5

15 acquisitions and 5 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment61/100

Weighted news tone is neutral across 59 relevant articles.

33 positive · 18 neutral · 8 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings82dNext report is scheduled for 19 Oct 2026; event risk rises as the date approaches.
Options expected move8.2%Nearest-chain priced movement where available.
52-week drawdown-11.3%Distance below the 52-week high.
13-week volatility5.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+14.5%Week of 26 Jun.
Worst week-21.1%Week of 24 Apr.
Latest week+11.8%Week of 24 Jul.

Shape of recent returns

Strong gains8
Modest gains6
Flat weeks0
Modest losses8
Sharp losses4
Recent vol5.0%13-week weekly-return volatility.
Base vol6.3%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -4.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape56/100

Trend, activity pressure, participation, and risk combine to a 56/100 tape read.

 Indicator analysis21/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 1/12.

Activity pressure 0.43; 3 reversal markers Factors53/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 27; Small Cap Core rank 97 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options56/100

MEDP shows mixed options pressure with a 41/100 conviction score, put-call volume ratio of 1.02, expected move of 8.2%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 8.2% Sentiment61/100

Weighted news tone is neutral across 59 relevant articles.

Medpace (MEDP) Stock May Be Below Fair Value On Raised Guidance Insiders15 / 5

15 acquisitions and 5 disposals in the latest 180-day insider tape.

 Earnings82d

Next report is scheduled for 19 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026601.4 USD11.8%495.0 USD391.6 USD1.098.072.8MOff
17 Jul 2026537.7 USD-0.1%493.9 USD389.4 USD0.98-4.721.3MOff
10 Jul 2026538.2 USD-3.5%494.9 USD387.5 USD0.82-8.131.5MOff
3 Jul 2026557.6 USD5.8%495.6 USD385.6 USD0.63-2.741.4MOff
26 Jun 2026527.1 USD14.5%495.3 USD383.5 USD0.33-6.822.0MOff
19 Jun 2026460.2 USD-1.5%497.5 USD381.7 USD-0.01-21.971.2MOff
12 Jun 2026467.3 USD2.9%501.8 USD380.2 USD-0.13-18.581.3MOff
5 Jun 2026454.2 USD1.6%505.9 USD378.6 USD-0.35-18.881.2MOff
29 May 2026447.1 USD3.3%510.4 USD377.0 USD-0.55-23.591.3MOff
22 May 2026432.8 USD4.2%515.0 USD375.5 USD-0.68-23.831.5MOff
15 May 2026415.3 USD-2.1%520.8 USD374.0 USD-0.77-25.991.8MOff
8 May 2026424.0 USD1.5%524.5 USD372.7 USD-0.62-24.681.8MOff
1 May 2026417.5 USD1.7%527.1 USD371.4 USD-0.56-21.782.5MOff
24 Apr 2026410.5 USD-21.1%530.9 USD370.0 USD-0.57-21.913.7MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.